High-Flow Versus VenturiMask Oxygen Therapy to Prevent Reintubation in Hypoxemic Patients after Extubation: A Multicenter Randomized Clinical Trial

adverse event oxygen therapy Respiratory failure Acute respiratory failure hazard ratio Mechanical ventilation 0302 clinical medicine acute respiratory failure; nasal high-flow oxygen; noninvasive ventilation; oxygen therapy; weaning nasal high-flow oxygen middle aged odds ratio endotracheal intubation Horowitz index weaning adult clinical trial 3. Good health female Respiratory Insufficiency Noninvasive ventilation extubation 610 Weaning reintubation Article intubation 03 medical and health sciences male Intubation, Intratracheal Humans controlled study human acute respiratory failure hypoxemia Noninvasive Ventilation respiratory failure Oxygen Inhalation Therapy noninvasive ventilation High-flow nasal oxygen Oxygen therapy major clinical study Oxygen High-flow nasal oxygen; Mechanical ventilation; Noninvasive ventilation; Respiratory failure; Weaning multicenter study confidence interval randomized controlled trial treatment outcome Airway Extubation [SDV.MHEP.PSR] Life Sciences [q-bio]/Human health and pathology/Pulmonology and respiratory tract Nasal high-flow oxygen oxygen high flow nasal cannula therapy
DOI: 10.1164/rccm.202201-0065oc Publication Date: 2022-07-18T19:54:47Z
ABSTRACT
Rationale: When compared with VenturiMask after extubation, high-flow nasal oxygen provides physiological advantages. Objectives: To establish whether prevents endotracheal reintubation in hypoxemic patients VenturiMask. Methods: In this multicenter randomized trial, 494 exhibiting PaO2:FiO2 ratio ⩽ 300 mm Hg extubation were randomly assigned to receive or oxygen, the possibility apply rescue noninvasive ventilation before reintubation. High-flow use group was not permitted. Measurements and Main Results: The primary outcome rate of within 72 hours according predefined criteria, which validated a posteriori by an independent adjudication committee. secondary outcomes included at 28 days need for criteria. After intubation criteria validation (n = 492 patients), 32 (13%) 27 (11%) required (unadjusted odds ratio, 1.26 [95% confidence interval (CI), 0.70–2.26]; P 0.49). At days, 21% 23% (adjusted hazard 0.89 CI, 0.60–1.31]; 0.55). significantly lower than group: hours, 8% versus 17% 0.39 0.22–0.71]; 0.002) 12% 0.52 0.32–0.83]; 0.007). Conclusions: Reintubation did differ between treated extubation. yielded less frequent ventilation. Clinical trial registered www.clinicaltrials.gov (NCT02107183).
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (56)
CITATIONS (30)